查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587793

全EXOME定序市场规模、份额、趋势分析报告：按产品、按技术、按工作流程、按应用、按最终用途、按地区、细分市场预测，2025-2030 年

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

全EXOME定序市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球全EXOME定序市场规模将达到12.725亿美元，2024年至2030年复合年增长率为18.44%。

推动市场的主要因素之一是全EXOME定序技术的进步。高通量技术正在广泛应用于临床诊断和研究，帮助医生更好地了解EXOME定序疾病并进行相应的治疗。此外，遗传疾病的日益流行使得能够采用全EXOME定序来询问蛋白质转录区并获得有关遗传变异的有价值的结果。

此外，资料分析和解释软体的可用性导致涉及全EXOME的研究显着增加。使用这些工具和软体来查询遗传资料很容易，并且可以为遗传异常和疾病的根本原因提供新的见解。例如，2022年5月，Illumina子公司Grail宣布与美国退伍军人事务部合作，为美国退伍军人提供Galleri多种癌症早期检测测试。此测试使用全EXOME定序来早期检测多种类型的癌症。这种伙伴关係体现了全EXOME定序和先进资料分析工具的使用如何实现大规模基因组研究并改变精准医学的未来。

市场受到 COVID-19 大流行的严重影响。英国基因组学联盟 (COVID-19 Genomics UK Consortium) 的研究就是利用全EXOME来增进我们对病毒及其传播的了解的一个例子。这场大流行也引起了人们EXOME定序在对抗感染疾病的前景的关注，并刺激了对该研究领域的额外投资。儘管2020年大流行带来了挑战，但预计未来几年整体市场将持续发展。

全EXOME定序市场报告亮点

  • 消耗品细分市场占据主导地位，2024年市场占有率为62.36%。这是因为全EXOMEEXOME定序需要多种耗材，包括试剂、套件和样品製备耗材，这些对于进行全外显子定序研究至关重要。
  • 2024年，合成定序领域市场占有率主导地位。这是因为合成定定序方法的有效性和经济性增加了它们的吸引力。
  • 由于基因检测服务和个人化医疗的需求不断增加，因此定序市场占有率市占率将达到49.90%。全EXOME定序能够以低成本分析大量遗传资料，并且还可以对遗传变异进行更全面的分析。
  • 由于在推动新药开发方面发挥重要作用，药物发现与开发领域在2024年以47.38%的市场占有率占据市场主导地位。全EXOME定序已成为识别基因突变和致病突变的强大方法，可用于开发量身定制的治疗方法。
  • 学术和研究机构部分在整个EXOME定序市场中占据主导地位，到 2024 年将占据 47.32% 的份额。该细分市场的主导地位是由于对个人化药物和医疗保健的需求不断增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章产品业务分析

  • 细分仪表板
  • 全EXOME定序市场：产品变异分析
  • 2018-2030 年全EXOME定序市场规模与趋势分析（依产品）
  • 装置
  • 消耗品
  • 服务

第五章技术业务分析

  • 细分仪表板
  • 全EXOME定序市场：技术变化分析
  • 2018-2030 年全EXOME定序市场规模与趋势分析（依技术）
  • SBS（定序定序）
  • ION半导体定序
  • 其他的

第 6 章 依工作流程进行业务分析

  • 细分仪表板
  • 全EXOME定序市场：工作流程变化分析
  • 2018-2030 年全EXOME定序市场规模与趋势分析（依工作流程）
  • 预测定序
  • 定序
  • 其他的

第七章 应用业务分析

  • 细分仪表板
  • 全EXOME定序市场：应用变异分析
  • 2018-2030 年全EXOME定序市场规模与趋势分析（按应用）
  • 临床诊断
  • 药物发现与开发
  • 个人化医疗
  • 其他的

第 8 章 依最终用途分类的业务分析

  • 细分仪表板
  • 全EXOME定序市场：最终用途变异分析
  • 2018-2030 年全EXOME定序市场规模与趋势分析（依最终用途）
  • 学术研究所
  • 医院/诊所
  • 製药和生物技术公司
  • 其他的

第九章区域业务分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 北美洲
    • 北美全EXOME定序市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲全EXOME定序市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区全EXOME定序市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲全EXOME定序市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲泛EXOME定序市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 公司分类
  • 策略规划
  • 2024 年企业市场占有率分析
  • 公司简介/
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc
    • BGI
    • PacBio
    • Oxford Nanopore Technologies plc.
    • Azenta US Inc.（GENEWIZ）
    • CD Genomics
    • Novogene Co, Ltd
    • Eurofins Genomics
Product Code: GVR-4-68040-070-5

Whole Exome Sequencing Market Growth & Trends:

The global whole exome sequencing market size is expected to reach USD 1,272.5 million by 2030, registering to grow at a CAGR of 18.44% from 2024 to 2030 according to a new report by Grand View Research, Inc. One of the primary factors driving the market is the advancement in technology for whole exome sequencing. High throughput technology is becoming more widely used in clinical diagnostics and research which helps doctors to better understand the exome sequence disorders and made a treatment accordingly. Additionally, the rising prevalence of genetic conditions has enabled the adoption of whole exome sequencing for the investigation of protein coding regions and the derivation of valuable output about genetic variants.

Additionally, the significant increase in research including whole exomes is driven by the availability of data analysis and interpretation software. The use of these tools and software to examine genetic data is easy and it provides a fresh insight into the underlying causes of genetic abnormalities and diseases. For instance, in May 2022, Illumina's subsidiary Grail, announced a partnership with the U.S. Department of Veterans Affairs, to provide their Galleri multi-cancer early detection test to U.S. veterans. This test utilizes whole exome sequences to detect multiple types of cancer in the early stages. This partnership exemplifies how the usage of whole exome sequencing and advanced data analysis tools can enable large-scale genomic research and transform the future of precision medicine.

The market has been significantly impacted by the COVID-19 pandemic. An example of how whole exomes have been used to better understand the virus and its dissemination is the COVID-19 Genomics UK Consortium study. The pandemic has also brought attention to the promise of exome sequence in the fight against infectious diseases, spurring additional investment in this field of study. The entire market is anticipated to develop in the upcoming years despite difficulties brought on by the pandemic in 2020.

Whole Exome Sequencing Market Report Highlights:

  • The consumables segment dominated the market in 2024 with a market share of 62.36%. This is due to whole exome sequencing's requirement of a variety of consumable items, including reagents, kits, and sample preparation consumables, which are essential for conducting whole exome sequencing investigations.
  • Sequencing by synthesis segment dominated the market in 2024 with a market share of 73.49%. This is due to the effectiveness and affordability of the sequencing by synthesis approach that has increased its appeal.
  • The sequencing segment had a dominating presence in the market in 2024 with a market share of 49.90%, due to the growing demand for genetic testing services and personalized medicine. Whole exome sequencing has the ability to analyze large number of genetic data in a less cost, additionally it allows for more comprehensive analysis of genetic variation.
  • Drug discovery & development segment dominated the market in 2024 with a market share of 47.38% due to it plays a crucial part in advancing the development of new drugs. Whole exome sequencing has become a compelling method for locating gene variations and disease-causing mutations that can be exploited to create tailored treatments.
  • The academic & research institutes segment in whole exome sequencing market dominated the market in 2024, with a share of 47.32%. The dominance of the segment is due to the increasing demand for personalized medicines and healthcare.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Workflow Segment
      • 1.1.1.4. Application Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Prevalence of Genetic Diseases
      • 3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
      • 3.2.1.3. Decreasing Costs of Sequencing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Whole Exome Sequencing Market: Product Movement Analysis
  • 4.3. Whole Exome Sequencing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Whole Exome Sequencing Market: Technology Movement Analysis
  • 5.3. Whole Exome Sequencing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Sequencing by Synthesis
    • 5.4.1. Sequencing By Synthesis Market, 2018 - 2030 (USD Million)
  • 5.5. ION Semiconductor Sequencing
    • 5.5.1. ION Semiconductor Sequencing Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other Technology Market, 2018 - 2030 (USD Million)

Chapter 6. Workflow Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Whole Exome Sequencing Market: Workflow Movement Analysis
  • 6.3. Whole Exome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 6.4. Pre-Sequencing
    • 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Sequencing
    • 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other Workflow Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Whole Exome Sequencing Market: Application Movement Analysis
  • 7.3. Whole Exome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Clinical Diagnostics
    • 7.4.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Drug Discovery & Development
    • 7.5.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 7.6. Personalized Medicines
    • 7.6.1. Personalized Medicines Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Whole Exome Sequencing Market: End Use Movement Analysis
  • 8.3. Whole Exome Sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Academic And Research Institutes
    • 8.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Other End use Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. North America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. U.S. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Canada Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Mexico Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. UK Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Germany Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. France Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Italy Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Spain Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Denmark Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Sweden Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Norway Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Japan Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. China Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. India Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Australia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Thailand Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. South Korea Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Brazil Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Argentina Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. South Africa Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Saudi Arabia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. UAE Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Kuwait Whole Exome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Illumina, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Agilent Technologies, Inc
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. BGI
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PacBio
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies plc.
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Azenta US Inc. (GENEWIZ)
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. CD Genomics
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Novogene Co, Ltd
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Eurofins Genomics
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 38 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 39 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 46 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 47 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 49 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 58 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 87 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 88 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 90 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 92 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 93 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 94 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 95 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 97 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 100 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 102 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 104 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 105 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 107 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 108 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 109 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 110 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 115 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 120 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Global whole exome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Global whole exome sequencing market driver analysis
  • Fig. 12 Global whole exome sequencing market restraint analysis
  • Fig. 13 Global whole exome sequencing market: Porter's analysis
  • Fig. 14 Global whole exome sequencing market: PESTEL analysis
  • Fig. 15 Global whole exome sequencing market: Product movement analysis
  • Fig. 16 Global whole exome sequencing market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global whole exome sequencing market, for consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global whole exome sequencing market, for services, 2018 - 2030 (USD Million)
  • Fig. 19 Global whole exome sequencing market: Technology movement analysis
  • Fig. 20 Global whole exome sequencing market, for sequencing by synthesis, 2018 - 2030 (USD Million)
  • Fig. 21 Global whole exome sequencing market, for ION semiconductor sequencing, 2018 - 2030 (USD Million)
  • Fig. 22 Global whole exome sequencing market, for other technology, 2018 - 2030 (USD Million)
  • Fig. 23 Global whole exome sequencing market: Workflow movement analysis
  • Fig. 24 Global whole exome sequencing market, for pre-sequencing, 2018 - 2030 (USD Million)
  • Fig. 25 Global whole exome sequencing market, for sequencing, 2018 - 2030 (USD Million)
  • Fig. 26 Global whole exome sequencing market, for data analysis, 2018 - 2030 (USD Million)
  • Fig. 27 Global whole exome sequencing market: Application movement analysis
  • Fig. 28 Global whole exome sequencing market, for clinical diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global whole exome sequencing market, for drug discovery & development, 2018 - 2030 (USD Million)
  • Fig. 30 Global whole exome sequencing market, for personalized medicine, 2018 - 2030 (USD Million)
  • Fig. 31 Global whole exome sequencing market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 32 Global whole exome sequencing market: End use movement analysis
  • Fig. 33 Global whole exome sequencing market, for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 34 Global whole exome sequencing market, for hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Global whole exome sequencing market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global whole exome sequencing market, for other end use, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional outlook, 2024 & 2030
  • Fig. 39 Global whole exome sequencing market: Region movement analysis
  • Fig. 40 North America whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 46 UK whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 47 France whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 55 China whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 56 India whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait whole exome sequencing market, 2018 - 2030 (USD Million)